HK1027975A1 - Pharmaceutical suspension comprising nevirapine hemihydrate. - Google Patents

Pharmaceutical suspension comprising nevirapine hemihydrate.

Info

Publication number
HK1027975A1
HK1027975A1 HK00107393A HK00107393A HK1027975A1 HK 1027975 A1 HK1027975 A1 HK 1027975A1 HK 00107393 A HK00107393 A HK 00107393A HK 00107393 A HK00107393 A HK 00107393A HK 1027975 A1 HK1027975 A1 HK 1027975A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical suspension
nevirapine hemihydrate
nevirapine
hemihydrate
pharmaceutical
Prior art date
Application number
HK00107393A
Other languages
English (en)
Inventor
Karl Georg Grozinger
Amale A Hawi
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1027975(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HK1027975A1 publication Critical patent/HK1027975A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00107393A 1997-08-25 2000-11-20 Pharmaceutical suspension comprising nevirapine hemihydrate. HK1027975A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25
PCT/US1998/016581 WO1999009990A1 (en) 1997-08-25 1998-08-11 Pharmaceutical suspension comprising nevirapine hemihydrate

Publications (1)

Publication Number Publication Date
HK1027975A1 true HK1027975A1 (en) 2001-02-02

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107393A HK1027975A1 (en) 1997-08-25 2000-11-20 Pharmaceutical suspension comprising nevirapine hemihydrate.

Country Status (38)

Country Link
US (2) US6172059B1 (cs)
EP (1) EP1019058B1 (cs)
JP (1) JP3472261B2 (cs)
KR (1) KR100426516B1 (cs)
CN (1) CN1197578C (cs)
AR (2) AR016869A1 (cs)
AT (1) ATE326971T1 (cs)
AU (1) AU742761B2 (cs)
BG (1) BG64337B1 (cs)
BR (1) BR9811994B1 (cs)
CA (1) CA2301646C (cs)
CL (1) CL2008003111A1 (cs)
CO (1) CO4970742A1 (cs)
CY (1) CY1105228T1 (cs)
CZ (1) CZ290667B6 (cs)
DE (1) DE69834655T2 (cs)
DK (1) DK1019058T3 (cs)
EG (1) EG24075A (cs)
ES (1) ES2265666T3 (cs)
HK (1) HK1027975A1 (cs)
HR (1) HRP980461B1 (cs)
HU (1) HU226063B1 (cs)
ID (1) ID21650A (cs)
IL (1) IL134185A (cs)
MY (1) MY122272A (cs)
NO (1) NO326226B1 (cs)
NZ (1) NZ503414A (cs)
PE (1) PE105799A1 (cs)
PL (1) PL192361B1 (cs)
PT (1) PT1019058E (cs)
RS (1) RS49808B (cs)
RU (1) RU2196584C2 (cs)
SA (1) SA98190680B1 (cs)
TR (1) TR200000490T2 (cs)
TW (1) TW450812B (cs)
UA (1) UA44370C2 (cs)
WO (1) WO1999009990A1 (cs)
ZA (1) ZA987623B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
EP1504040A1 (en) * 2002-04-23 2005-02-09 Boehringer Ingelheim Pharmaceuticals Inc. Method for reduction of residual organic solvent in carbomer
AU2006286314A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
US9273049B2 (en) * 2009-11-10 2016-03-01 North-West University Method for increasing the solubility of nevirapine
BR112012014762A2 (pt) * 2009-12-17 2016-03-29 Univ Northwest forma polimorfa de nevirapina e sua preparação

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
CA2301646C (en) 2008-11-18
PE105799A1 (es) 1999-11-16
BR9811994A (pt) 2000-09-05
IL134185A (en) 2005-11-20
TW450812B (en) 2001-08-21
RS49808B (sr) 2008-08-07
BG64337B1 (bg) 2004-10-29
BR9811994B1 (pt) 2013-11-19
WO1999009990A1 (en) 1999-03-04
AR016869A1 (es) 2001-08-01
AU742761B2 (en) 2002-01-10
PL338828A1 (en) 2000-11-20
AU8777198A (en) 1999-03-16
ID21650A (id) 1999-07-08
DK1019058T3 (da) 2006-06-12
EP1019058A1 (en) 2000-07-19
HUP0003093A2 (hu) 2001-08-28
EG24075A (en) 2008-05-11
CA2301646A1 (en) 1999-03-04
EP1019058A4 (en) 2004-11-10
CY1105228T1 (el) 2010-03-03
YU9800A (sh) 2001-12-26
KR100426516B1 (ko) 2004-04-13
IL134185A0 (en) 2001-04-30
UA44370C2 (uk) 2002-02-15
ES2265666T3 (es) 2007-02-16
BG104133A (en) 2000-08-31
DE69834655D1 (de) 2006-06-29
ZA987623B (en) 2000-03-22
CL2008003111A1 (es) 2009-09-11
EP1019058B1 (en) 2006-05-24
DE69834655T2 (de) 2006-12-14
SA98190680B1 (ar) 2006-04-04
CN1197578C (zh) 2005-04-20
TR200000490T2 (tr) 2000-08-21
PL192361B1 (pl) 2006-10-31
JP3472261B2 (ja) 2003-12-02
HU226063B1 (hu) 2008-04-28
CZ2000694A3 (cs) 2000-09-13
ATE326971T1 (de) 2006-06-15
PT1019058E (pt) 2006-08-31
NO20000906L (no) 2000-02-24
US6172059B1 (en) 2001-01-09
JP2001513564A (ja) 2001-09-04
HRP980461A2 (en) 1999-06-30
AR083451A2 (es) 2013-02-27
RU2196584C2 (ru) 2003-01-20
NO326226B1 (no) 2008-10-20
KR20010023257A (ko) 2001-03-26
NZ503414A (en) 2002-11-26
US6255481B1 (en) 2001-07-03
CO4970742A1 (es) 2000-11-07
NO20000906D0 (no) 2000-02-24
MY122272A (en) 2006-04-29
CN1268055A (zh) 2000-09-27
HRP980461B1 (en) 2002-08-31
CZ290667B6 (cs) 2002-09-11

Similar Documents

Publication Publication Date Title
PL340337A1 (en) Drugs
HK1027957A1 (en) Pharmaceutical composition.
GB9700504D0 (en) Pharmaceutical compounds
GB9706089D0 (en) Pharmaceutical composition
ZA981029B (en) Pharmaceutical agents.
ZA9811504B (en) Novel pharmaceutical.
ZA9811506B (en) Novel pharmaceutical.
ZA989680B (en) Pharmaceutical composition.
GB9815532D0 (en) Pharmaceutical suspension formulation
EG23694A (en) Novel pharmaceutical
EP1003495A4 (en) PHARMACEUTICAL COMPOUNDS
GB9716244D0 (en) Pharmaceutical compounds
ZA982073B (en) Pharmaceutical preparation
ZA987392B (en) Pharmaceutical composition.
AU4001297A (en) Capsule
ZA987623B (en) Pharmaceutical suspension comprising nevirapine hemihydrate.
IL122920A (en) Castrointestinal drug composition
GB9700895D0 (en) Pharmaceutical compounds
ZA982558B (en) Novel Pharmaceutical.
GB2321190B (en) Pharmaceutical composition
IL126732A0 (en) Pro drug
IL120319A0 (en) Pharmaceutical preparation
GB9828707D0 (en) Pharmaceutical uses
CA82556S (en) Capsule
ZA978066B (en) Pharmaceutical compounds.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150811